Try our mobile app

Switch to company model in classical logic    *

General information

Country: ISRAEL

Sector: Medical Devices

InMode Ltd. develops medical devices. The Company manufactures and markets platforms that harness novel radio-frequency based technology for both the patients and the practitioners. InMode serves customers worldwide.
Website: inmodemd.com



Growth: Good revenue growth rate 28.7%, there is slowdown compared to average historical growth rates 51.7%. The revenue growth dynamics is moderately stable Site traffic for the last 3 months showed a change of -3.8%

Profitability: LTM EBITDA margin is positive, +43.5%. On average the margin is decreasing unsteadily. Gross margin is high, +84.5%. In the last quarter the company beat the estimated EPS, +10.6%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.07 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 6.2% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 0.0% higher than minimum and 82.3% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 5.8x by EV / Sales multiple , the company can be >100% undervalued

Key Financials (Download financials)

Ticker: INMD
Share price, USD:  (-0.6%)17.34
year average price 28.90  


year start price 37.44 2023-04-21

max close price 46.04 2023-07-19

min close price 17.34 2024-04-18

current price 17.34 2024-04-19
Common stocks: 83 081 105

Dividend Yield:  0.0%
FCF Yield LTM: 6.2%
EV / LTM EBITDA: 5.5x
EV / EBITDA annualized: 5.3x
Last revenue growth (y/y):  28.7%
Last growth of EBITDA (y/y):  8.9%
Historical revenue growth:  51.7%
Historical growth of EBITDA:  62.4%
EV / Sales: 2.4x
Margin (EBITDA LTM / Revenue): 43.5%
Fundamental value created in LTM:
Market Cap ($m): 1 441
Net Debt ($m): -408
EV (Enterprise Value): 1 033
Price to Book: 1.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-04-03Zacks Investment Research

InMode (INMD) Ascends But Remains Behind Market: Some Facts to Note

2024-04-01Zacks Investment Research

Is InMode (INMD) a Buy as Wall Street Analysts Look Optimistic?

2024-03-28Zacks Investment Research

Why InMode (INMD) Outpaced the Stock Market Today

2024-03-21Zacks Investment Research

InMode (INMD) Stock Falls Amid Market Uptick: What Investors Need to Know

2024-03-19Zacks Investment Research

InMode Ltd. (INMD) Is a Trending Stock: Facts to Know Before Betting on It

2024-03-15Zacks Investment Research

Why InMode (INMD) Dipped More Than Broader Market Today

2024-03-15Zacks Investment Research

Brokers Suggest Investing in InMode (INMD): Read This Before Placing a Bet

2024-02-23Zacks Investment Research

Is It Worth Investing in InMode (INMD) Based on Wall Street's Bullish Views?

2024-02-05Zacks Investment Research

Here's Why InMode (INMD) Fell More Than Broader Market

2024-01-30Zacks Investment Research

InMode (INMD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol INMD INMD INMD INMD INMD INMD
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-13 2023-11-02 2023-07-27 2023-05-02 2022-12-31 2022-09-30
acceptedDate 2024-02-13 07:03:05 2023-11-02 07:30:59 2023-07-27 07:00:08 2023-05-02 07:00:13 2022-12-30 19:00:00 2022-09-29 20:00:00
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
revenue 127M 123M 136M 106M 134M 121M
costOfRevenue 20M 20M 22M 18M 21M 19M
grossProfit 107M 103M 114M 88M 113M 102M
grossProfitRatio 0.840 0.836 0.838 0.828 0.843 0.845
researchAndDevelopmentExpenses 3M 3M 4M 3M 3M 3M
generalAndAdministrativeExpenses 2M 2M 2M 2M 2M 2M
sellingAndMarketingExpenses 49M 51M 51M 42M 47M 43M
sellingGeneralAndAdministrativeExpenses 52M 53M 53M 44M 49M 46M
otherExpenses 0 0 0 0 0 0
operatingExpenses 55M 57M 57M 47M 53M 49M
costAndExpenses 76M 77M 79M 65M 74M 67M
interestIncome 9M 5M 0 3M 4M 0
interestExpense 0 0 0 -3M 4M 189 000
depreciationAndAmortization 122 000 129 000 184 000 188 000 218 000 169 000
ebitda 51M 47M 57M 41M 60M 54M
ebitdaratio 0.405 0.378 0.420 0.388 0.450 0.445
operatingIncome 51M 46M 57M 41M 60M 54M
operatingIncomeRatio 0.404 0.377 0.419 0.386 0.448 0.443
totalOtherIncomeExpensesNet 9M 5M 4M 3M 4M 189 000
incomeBeforeTax 60M 51M 61M 44M 64M 54M
incomeBeforeTaxRatio 0.475 0.417 0.452 0.418 0.478 0.445
incomeTaxExpense 5M 5M 6M 4M 26M 5M
netIncome 55M 47M 56M 41M 38M 49M
netIncomeRatio 0.435 0.378 0.410 0.382 0.282 0.402
eps 0.660 0.560 0.670 0.490 0.460 0.590
epsdiluted 0.640 0.540 0.650 0.470 0.440 0.580
weightedAverageShsOut 84M 84M 83M 83M 82M 82M
weightedAverageShsOutDil 86M 86M 86M 85M 85M 85M
link Link Link Link Link
finalLink Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol INMD INMD INMD INMD INMD INMD
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-13 2023-11-02 2023-07-27 2023-05-02 2022-12-31 2022-09-30
acceptedDate 2024-02-13 07:03:05 2023-11-02 07:30:59 2023-07-27 07:00:08 2023-05-02 07:00:13 2022-12-30 19:00:00 2022-09-29 20:00:00
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 144M 134M 160M 93M 98M 77M
shortTermInvestments 597M 542M 470M 481M 450M 409M
cashAndShortTermInvestments 742M 676M 629M 574M 547M 486M
netReceivables 44M 62M 51M 40M 42M 42M
inventory 45M 40M 39M 41M 40M 36M
otherCurrentAssets 15M 19M 0 0 14M 0
totalCurrentAssets 845M 778M 719M 655M 629M 564M
propertyPlantEquipmentNet 12M 9M 8M 8M 7M 7M
goodwill 0 0 0 0 0 0
intangibleAssets 0 0 0 0 0 0
goodwillAndIntangibleAssets 0 0 0 0 0 0
longTermInvestments 700 000 600 000 600 000 600 000 600 000 600 000
taxAssets 2M 2M 2M 2M 3M 3M
otherNonCurrentAssets 4M 4M 4M 4M 4M 4M
totalNonCurrentAssets 18M 16M 15M 15M 15M 15M
otherAssets 0 0 0 0 0 0
totalAssets 863M 794M 734M 670M 644M 579M
accountPayables 14M 12M 13M 12M 16M 13M
shortTermDebt 2M 0 0 0 1M 0
taxPayables 2M 0 0 0 19M 0
deferredRevenue 11M 11M 11M 17M 14M 12M
otherCurrentLiabilities 37M 39M 36M 30M 51M 32M
totalCurrentLiabilities 64M 62M 61M 60M 82M 58M
longTermDebt 7M 4M 4M 4M 4M 4M
deferredRevenueNonCurrent 4M 4M 3M 3M 4M 4M
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0
otherNonCurrentLiabilities 1M 762 000 533 000 391 000 303 000 -13M
totalNonCurrentLiabilities 12M 8M 7M 7M 8M 13M
otherLiabilities 0 0 0 0 0 0
capitalLeaseObligations 9M 4M 4M 4M 4M 4M
totalLiabilities 76M 70M 68M 67M 90M 71M
preferredStock 0 0 0 0 0 0
commonStock 245 000 723M 0 0 241 000 0
retainedEarnings 693M 0 0 0 496M 0
accumulatedOtherComprehensiveIncomeLoss -2M 0 0 0 -7M 0
othertotalStockholdersEquity 95M 0 0 0 66M 0
totalStockholdersEquity 787M 723M 666M 603M 555M 508M
totalEquity 787M 723M 666M 603M 555M 508M
totalLiabilitiesAndStockholdersEquity 863M 794M 734M 670M 644M 579M
minorityInterest 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 863M 794M 734M 670M 644M 579M
totalInvestments 598M 543M 470M 482M 450M 410M
totalDebt 9M 4M 4M 4M 5M 4M
netDebt -135M -130M -156M -89M -93M -73M
link Link Link Link Link
finalLink Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol INMD INMD INMD INMD INMD INMD
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-13 2023-11-02 2023-07-27 2023-05-02 2022-12-31 2022-09-30
acceptedDate 2024-02-13 07:03:05 2023-11-02 07:30:59 2023-07-27 07:00:08 2023-05-02 07:00:13 2022-12-30 19:00:00 2022-09-29 20:00:00
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
netIncome 55M 47M 56M 41M 38M 49M
depreciationAndAmortization 122 000 129 000 184 000 188 000 218 000 169 000
deferredIncomeTax -30 000 -216 000 43 000 19 000 -72 000 9000.000
stockBasedCompensation 6M 7M 7M 4M 7M 8M
changeInWorkingCapital 813 000 -11M -9M -22M 15M -12M
accountsReceivables 377 000 -11M -8M 2M 805 000 -7M
inventory -5M -1M 2M -914 000 -4M -6M
accountsPayables 2M -962 000 1M -4M 3M 1M
otherWorkingCapital 4M 2M -4M -19M 15M -367 000
otherNonCashItems -1M -101 000 -936 000 -2M -3M 648 000
netCashProvidedByOperatingActivities 61M 41M 53M 21M 57M 46M
investmentsInPropertyPlantAndEquipment -21 000 -149 000 -194 000 -341 000 -328 000 -387 000
acquisitionsNet 0 70M 0 0 21M 0
purchasesOfInvestments 40M -240M -154M -124M -71M -107M
salesMaturitiesOfInvestments -91M 170M 167M 97M 33M 51M
otherInvestingActivites 0 -70M 0 0 -21M 0
netCashUsedForInvestingActivites -52M -70M 13M -28M -38M -56M
debtRepayment 0 0 0 0 0 0
commonStockIssued 246 716 3M 0 0 0 0
commonStockRepurchased 0 0 0 0 43M 0
dividendsPaid 0 0 0 0 0 0
otherFinancingActivites 28 284 124 675 0 0 -42M 550 000
netCashUsedProvidedByFinancingActivities 275 000 3M 827 000 2M 637 000 550 000
effectOfForexChangesOnCash 827 000 -473 000 60 000 191 000 978 000 -1M
netChangeInCash 11M -26M 67M -5M 20M -11M
cashAtEndOfPeriod 144M 134M 160M 93M 98M 77M
cashAtBeginningOfPeriod 134M 160M 93M 98M 77M 88M
operatingCashFlow 61M 41M 53M 21M 57M 46M
capitalExpenditure -21 000 -149 000 -194 000 -341 000 -328 000 -387 000
freeCashFlow 61M 41M 53M 21M 57M 45M
link Link Link Link Link
finalLink Link Link Link Link

Earning call transcript

2023 q4
2024-02-13 ET (fiscal 2023 q4)
2023 q3
2023-11-02 ET (fiscal 2023 q3)
2023 q2
2023-07-27 ET (fiscal 2023 q2)
2023 q1
2023-05-02 ET (fiscal 2023 q1)
2022 q4
2023-02-14 ET (fiscal 2022 q4)
2022 q3
2022-10-27 ET (fiscal 2022 q3)
2022 q2
2022-07-28 ET (fiscal 2022 q2)
2022 q1
2022-05-02 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-02-13 12:00 ET
InMode Reports Fourth Quarter and Full Year 2023 Financial Results; Quarterly Revenue of $126.8M and Record Full Year Revenue of $492M
2024-01-16 12:00 ET
InMode to Report Fourth Quarter & Full Year 2023 Financial Results and Hold Conference Call on Feb. 13, 2024, Expects Q4 Revenue Between $126.0M-$126.5M
2023-12-06 12:00 ET
InMode Revises Full-Year 2023 Guidance
2023-11-06 13:30 ET
InMode to Present at Upcoming Investor Conferences and Events
2023-11-02 11:00 ET
InMode Reports Third Quarter 2023 Financial Results; Quarterly Revenue of $123.1M Represents 2% Year-Over-Year Growth
2023-10-13 12:00 ET
InMode Files Patent Infringement Complaint Against BTL Industries, Inc. (d/b/a BTL Aesthetics)
2023-10-12 12:00 ET
InMode Expects Third Quarter 2023 Revenue Between $122.8M-$123.0M, Lowering Full-Year 2023 Revenue Guidance to $500M-$510M vs. Original Estimates of $530M-$540M
2023-10-09 20:44 ET
InMode Affirms Safety of Management, Employees and Production Sites
2023-09-05 12:00 ET
InMode to Present at Upcoming Investor Conferences and Events
2023-08-01 12:00 ET
InMode to Present at Upcoming Investor Conferences and Events
2023-07-27 11:00 ET
InMode Reports Second Quarter 2023 Financial Results; Record Quarterly Revenue of $136.1M Represents 20% Year-Over-Year Growth
2023-07-25 12:00 ET
InMode Expands Women's Health and Wellness Market Footprint through Acquisition of Viveve Patents
2023-07-12 11:00 ET
InMode Expects Second Quarter 2023 Revenue Between $135.7-$135.9M, Increases Full Year 2023 Guidance, Expects Revenues of $530-540M
2023-05-17 12:30 ET
InMode to Present at Upcoming Investor Conferences and Events
2023-05-02 11:00 ET
InMode Reports First Quarter 2023 Financial Results; Quarterly Revenue of $106.1M Represents 23.5% Year-Over-Year Growth
2023-04-12 11:00 ET
InMode Expects First Quarter 2023 Revenue Between $105.7-$105.9M, Non-GAAP Earnings per Diluted Share Between $0.50-$0.51
2023-03-13 12:00 ET
InMode Updates It Does Not Hold Cash Deposits at SVB
2023-03-02 13:30 ET
InMode to Present In-Person at the Barclays Global Health Conference
2023-02-14 12:00 ET
InMode Reports Fourth Quarter and Full Year 2022 Financial Results; Record Quarterly Revenue of $133.6M Represents 21% Year-Over-Year Growth
2023-01-11 12:00 ET
InMode Expects Record Fourth Quarter & Full Year 2022 Financial Results, Q4 Revenue Between $133.2M-$133.4M
2023-01-03 13:00 ET
InMode to Present at the 25th Annual Needham Growth Conference
2022-11-22 16:32 ET
BoomerangFX E-Learning platform expands to Asia-Pacific and Europe
2022-11-01 12:00 ET
InMode to Present at Upcoming Investor Conferences Before the End of 2022
2022-10-27 11:00 ET
InMode Reports Third Quarter 2022 Financial Results; Record Quarterly Revenue of $121.2 M, Represents 29% Year-Over-Year Growth
2022-10-13 12:00 ET
InMode Expects Record Third Quarter 2022 Revenue of $120.5M-$120.9M, Raising Full-Year 2022 Revenue Guidance to $445M-450M
2022-09-29 12:00 ET
Eva Longoria Announced as InMode Global Brand Ambassador
2022-08-30 12:00 ET
InMode to Present at the Baird 2022 Global Healthcare Conference
2022-08-08 12:00 ET
InMode to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1-on-1 Conference
2022-07-28 11:00 ET
InMode Reports Second Quarter 2022 Financial Results; Record Quarterly Revenue of $113.5M, Represents 30% Year-Over-Year Growth
2022-07-20 12:00 ET
InMode to Present at the Canaccord 42nd Annual Growth Conference
2022-07-12 12:00 ET
InMode Expects Record Second Quarter 2022 Financial Results, Revenue Between $113.0-$113.3M, Increasing Full Year 2022 Revenue Guidance to $425-$435M
2022-06-15 12:03 ET
InMode Receives Health Canada Certification of EmpowerRF Women's Wellness Technology
2022-05-23 12:00 ET
InMode to Participate at the UBS Healthcare One-on-One Virtual Day
2022-05-02 11:00 ET
InMode Reports First Quarter 2022 Financial Results:
2022-04-11 12:00 ET
InMode Expects First Quarter 2022 Revenue Between $85.0-$85.5M, Non-GAAP Earnings per Diluted Share Between $0.38-$0.39
2022-04-05 12:00 ET
InMode to Participate Virtually in a Fireside Chat at the 21st Annual Needham Healthcare Conference
2022-03-10 13:00 ET
InMode Announces Share Repurchase Program of Up to 1 Million Shares
2022-03-02 13:00 ET
InMode to Participate in Investor Conferences in March
2022-02-10 12:00 ET
InMode Reports Record Fourth Quarter and Full Year 2021 Financial Results:
2022-01-12 12:30 ET
InMode Expects Record Fourth Quarter & Full Year 2021 Financial Results, Q4 Revenue Between $109.5M-$110M
2022-01-03 13:00 ET
InMode to Present at the 24th Needham Virtual Growth Conference
2021-11-04 12:00 ET
InMode to Participate in Upcoming Virtual Investor Conferences in November
2021-10-26 11:30 ET
InMode Reports Record Third Quarter 2021 Financial Results: Quarterly Revenue of $94.2M, 58% Year-Over-Year Growth; GAAP Net Income of $44.7M, 87% increase compared to Q3 2020
2021-10-12 12:00 ET
InMode Expects Record Third Quarter 2021 Revenue of $93.5M-$94M, Raising Full-Year 2021 Revenue Guidance to $343M-$347M
2021-09-17 12:00 ET
InMode Ltd. Announces 2-for-1 Share Split
2021-09-09 12:00 ET
InMode to Participate in Upcoming Virtual Conferences in September
2021-09-01 13:03 ET
InMode Announces Launch of EvolveX Body Transforming Platform
2021-08-17 13:03 ET
InMode Announces Launch of EmpowerRF Women's Wellness Platform
2021-08-03 13:39 ET
InMode to Participate in Upcoming August Conferences
2021-07-28 11:00 ET
InMode Reports Record Second Quarter 2021 Financial Results: Quarterly Revenues of $87.3 Million Represent 184% Year Over Year Growth
2021-07-12 12:00 ET
InMode Expects Record Second Quarter 2021 Revenue Between $86.5M-$87.0M, Increasing Full Year 2021 Revenue Guidance to $305-$315M
2021-05-27 20:05 ET
InMode to Present at the Jefferies Virtual Healthcare Conference
2021-05-13 12:00 ET
InMode to Present at the UBS Global Healthcare Virtual Conference
2021-05-05 11:15 ET
InMode Reports First Quarter 2021 Financial Results: Quarterly Revenues of $65.5 Million Represent 62% Year over Year Growth. GAAP Earnings per Share of $0.63, 320% Year over Year Growth
2021-04-12 11:45 ET
InMode Expects First Quarter 2021 Revenue Between $65.0-$65.4M, Non-GAAP Earnings per Diluted Share Between $0.65-$0.67
2021-03-30 12:00 ET
InMode to Present at the Needham 20th Annual Virtual Healthcare Conference
2021-03-16 11:30 ET
InMode Files ITC Complaint Against ILOODA and its U.S. Distributor, Cutera
2021-02-10 12:15 ET
InMode Reports Record Fourth Quarter and Full Year 2020 Financial Results; Quarterly Revenues of $75.2 Million Represent 60% Year over Year Growth
2021-01-12 13:00 ET
InMode Expects Record Fourth Quarter and Full Year 2020 Results, Fourth Quarter Revenue Between $74.5-$75M, Non-GAAP Earnings per Diluted Share Between $0.91-$0.93; Announces 2021 Full Year Revenue Guidance of $250- $260M
2021-01-11 13:00 ET
InMode to Participate at the 2021 ICR Conference
2021-01-06 13:00 ET
InMode Announces Corporate Social Responsibility Strategy
2021-01-05 13:00 ET
InMode to Present at the 23rd Annual Needham Growth Conference
2020-11-16 17:30 ET
Oasis Treatment Tent by La Belle Vie MedSpa featuring InMode
2020-11-12 12:15 ET
InMode Reports Record Third Quarter 2020 Financial Results; Quarterly Revenues of $59.7 Million Represent 49% Year over Year Growth, GAAP and *Non-GAAP Diluted Earnings per Share of $0.57 and $0.63
2020-11-11 16:30 ET
Nanowear Receives FDA 510(k) Clearance for SimpleSENSE, a Cloth-Based Wearable Remote Diagnostic Monitoring Platform
2020-11-11 13:00 ET
InMode Announces US Patent for Fractional RF (Morpheus8)
2020-11-10 13:00 ET
Plume Effect of Fractional Radiofrequency Versus Laser Resurfacing: Considerations in the COVID Pandemic
2020-11-02 13:00 ET
InMode to Present at Upcoming Virtual Investor Conferences in November
2020-10-20 12:00 ET
InMode Introduces Morpheus8 Body Multi-pulse Burst Technology
2020-10-13 12:00 ET
InMode Expects Record Third Quarter Results, Revenues Between $59.2-$59.5M, Non-GAAP Earnings per Diluted Share Between $0.60-$0.62; Increasing Full Year 2020 Revenue Guidance to $192-$195M
2020-09-02 12:00 ET
InMode Announces Share Repurchase Program of Up to 1 Million Shares
2020-08-13 12:00 ET
InMode Introduces the Morpheus8 Platform and the Morpheus8 Body Fractional Technology
2020-08-05 11:00 ET
InMode Reports Second Quarter 2020 Financial Results; Quarterly Revenues of $30.8 Million, GAAP and *Non-GAAP Diluted Earnings per Share of $0.21 and $0.24
2020-08-03 12:00 ET
InMode to Present at Upcoming Virtual Conferences in August
2020-07-27 12:00 ET
InMode Technologies Win Major Beauty Awards
2020-07-13 12:00 ET
InMode to Report Second Quarter 2020 Financial Results on August 5, 2020; Management Expects Q2 Revenues to be Between $30.2-$30.6M, Non-GAAP Earnings per Diluted Share Between $0.20-$0.22, Full Year 2020 Revenue to be No Less than Full Year 2019 Revenue
2020-07-06 12:00 ET
InMode Announces NMPA (formerly CFDA) Approval for Two InMode Platforms in China
2020-06-16 12:00 ET
InMode Receives Health Canada Certification for Evolve Tone
2020-05-11 12:00 ET
InMode to Participate at Upcoming Virtual Investor Conferences
2020-05-06 11:00 ET
InMode Reports First Quarter 2020 Financial Results; Quarterly Revenues of $40.4 Million Represent 32% Year over Year Growth
2020-04-07 12:00 ET
InMode to Report First Quarter 2020 Financial Results on May 6, 2020
2020-03-23 12:47 ET
InMode Provides COVID-19 Business Update
2020-03-02 13:00 ET
InMode to Present at Barclays Global Healthcare Conference
2020-02-24 13:00 ET
InMode Receives Health Canada Certification for Evoke
2020-02-18 13:00 ET
InMode Reports Record Fourth Quarter and Full Year 2019 Financial Results
2020-01-29 13:00 ET
InMode to Participate in IMCAS World Congress in Paris
2020-01-27 13:00 ET
InMode Launches Evoke, the First and Only Hands-free Facial Remodeling Technology
2020-01-21 13:00 ET
InMode Launches Newest MedTech Innovation: Evolve Hands-free Platform
2020-01-13 13:00 ET
InMode Expects to Report Fourth Quarter and Full Year 2019 Financial Results on February 18, 2020
2019-11-07 15:26 ET
InMode Supporting Operation Smile with Charitable Donation
2019-11-05 13:00 ET
InMode Reports Third Quarter 2019 Record Revenue of $40 Million; Reflects Growth of 57% Year-Over-Year; Net Income Increased 87% to $16.2 Million
2019-10-31 13:00 ET
InMode Receives Health Canada Certification for Multiple New Products
2019-10-10 12:00 ET
InMode to Report Third Quarter 2019 Financial Results on November 5, 2019
2019-10-03 12:00 ET
InMode Establishes Two New Sales & Marketing Subsidiaries in India and Australia
2019-09-10 12:00 ET
InMode's Inaugural Insider Summit Attracts Over 600 Attendees
2019-08-27 16:14 ET
InMode to Participate in 5CC International Conference in Barcelona
2019-08-20 20:05 ET
InMode Ltd. Announces Exercise of Over-Allotment Option
2019-08-13 20:05 ET
InMode Reports Second Quarter 2019 Financial Results; Record Quarterly Revenue of $38.8 Million Reflects Growth of 55% Over Prior Year
2019-08-13 12:00 ET
Paula Abdul Announced as InMode Brand Ambassador
2019-08-12 20:10 ET
InMode Ltd. Announces Closing of Initial Public Offering
2019-08-08 00:40 ET
InMode Ltd. Announces Pricing of Initial Public Offering

SEC forms

Show financial reports only

SEC form 6
2024-02-13 07:06 ET
Inmode published news for 2023 q4
SEC form 6
2024-02-13 07:06 ET
Inmode published news for 2023 q4
SEC form 6
2024-02-13 07:01 ET
Inmode published news for 2023 q4
SEC form 6
2024-02-13 07:01 ET
Inmode reported for 2023 q4
SEC form 6
2023-11-02 07:30 ET
Inmode reported for 2023 q3
SEC form 6
2023-07-27 07:00 ET
Inmode reported for 2023 q2
SEC form 6
2023-04-04 07:15 ET
Inmode published news for 2023 q1
SEC form 6
2023-02-14 07:08 ET
Inmode published news for 2022 q4
SEC form 6
2023-02-14 07:03 ET
Inmode reported for 2022 q4
SEC form 6
2023-02-14 07:00 ET
Inmode reported for 2022 q4
SEC form 6
2022-10-27 07:00 ET
Inmode reported for 2022 q3
SEC form 6
2022-07-28 07:00 ET
Inmode published news for 2022 q2
SEC form 6
2022-05-02 07:00 ET
Inmode published news for 2022 q1
SEC form 6
2022-04-06 07:30 ET
Inmode published news for 2022 q1
SEC form 6
2022-03-10 07:30 ET
Inmode published news for 2021 q4
SEC form 6
2022-02-10 07:07 ET
Inmode published news for 2021 q4
SEC form 6
2022-02-10 07:05 ET
Inmode reported for 2021 q4
SEC form 6
2022-02-10 07:00 ET
Inmode published news for 2021 q4
SEC form 6
2021-10-26 07:30 ET
Inmode reported for 2021 q3
SEC form 6
2021-09-17 08:04 ET
Inmode published news for 2021 q2
SEC form 6
2021-07-28 07:00 ET
Inmode published news for 2021 q2
SEC form 6
2021-05-05 07:30 ET
Inmode reported for 2021 q1
SEC form 6
2021-04-26 07:30 ET
Inmode published news for 2021 q1
SEC form 6
2021-04-08 07:30 ET
Inmode published news for 2021 q1
SEC form 6
2021-02-10 07:23 ET
Inmode published news for 2020 q4
SEC form 6
2021-02-10 07:19 ET
Inmode published news for 2020 q4
SEC form 6
2021-02-10 07:15 ET
Inmode reported for 2020 q4
SEC form 6
2020-11-12 07:00 ET
Inmode published news for 2020 q3